about
Prescription Sedative Misuse and AbuseBenzodiazepine Use During Hospitalization: Automated Identification of Potential Medication Errors and Systematic Assessment of Preventable Adverse EventsInfluence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometryAnxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease.Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in ratsRisks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.Effects of Prereactivation Propranolol on Cocaine Craving Elicited by Imagery Script/Cue Sets in Opioid-dependent Polydrug Users: A Randomized Study.A pilot study of serotonin-1A receptor genotypes and rapid eye movement sleep sensitivity to serotonergic/cholinergic imbalance in humans: a pharmacological model of depression.Effects of 25 mg oxazepam on emotional mimicry and empathy for pain: a randomized controlled experiment.Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects.The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine.The effects of galantamine and buspirone on sleep structure: Implications for understanding sleep abnormalities in major depression.Lorazepam as a Cause of Drug-Induced Liver Injury
P2860
Q26785474-352EECB6-45FA-4BEF-BB70-ACF508DBF2F8Q28554558-446B2C9F-52E2-415C-B93E-527CA03BB127Q30404054-759EDD91-B684-4D9E-8DE8-A83944277BB3Q30438962-C1134CF2-81DD-4115-A221-24914FD2FD4BQ30593914-F31D36A0-2107-4717-A0AD-445F303BDA47Q33753044-6778674A-67C6-4AD3-8F42-9BE754A78EEDQ36240266-BA78B91A-545B-46B4-ADB2-0548035355B2Q36402857-47A86203-954A-4485-9930-4701987B9264Q37740798-A9667B6A-03C0-4E72-8E10-209107927173Q47622865-C78BE767-876F-48A7-BB95-C3EFBE8F64A6Q47693272-F9C914C0-EE7B-4E23-AED0-62DE8F4A8D4DQ47948093-F13F3FCD-9676-4ED6-856B-ACFFFAB856DAQ57130314-DBF676BF-8531-4251-B62B-96B56DFCB34D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding the pharmacokinetics of anxiolytic drugs.
@en
type
label
Understanding the pharmacokinetics of anxiolytic drugs.
@en
prefLabel
Understanding the pharmacokinetics of anxiolytic drugs.
@en
P2093
P2860
P1476
Understanding the pharmacokinetics of anxiolytic drugs.
@en
P2093
Alfredo Carlo Altamura
Donatella Moliterno
Massimo Carlo Mauri
Michele Maffini
Silvia Paletta
Silvio Bareggi
P2860
P304
P356
10.1517/17425255.2013.759209
P407
P577
2013-01-21T00:00:00Z